Summary:
- This article discusses a new drug that has shown promise in treating Parkinson's disease, a neurological disorder that affects movement and coordination.
- The drug, called ABBV-951, was found to be more effective than the current standard treatment in reducing the symptoms of Parkinson's disease in clinical trials.
- The article explains that ABBV-951 works by delivering a key Parkinson's medication directly to the brain, which could lead to better management of the disease and improved quality of life for patients.